NEW YORK — The U.S. cancer death rate has hit a milestone: It’s been falling for at least 25 years, according to a new report. Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also…
By Mike Stobbe, Associated Press
Endometrial cancer, a common form of uterine cancer, has an 80 percent rate of survival over a five-year period in most women diagnosed at age 60 and above. But African American women are more likely to have a more aggressive…
By Dr. Amber Robins
The revised Republican plan to replace Obamacare gained key endorsements from two moderate Republican holdouts, who were convinced that a new amendment would help cover people with pre-existing conditions. Will the plan garner enough support? Judy Woodruff gets reaction from…
By PBS NewsHour
Colon and rectal cancer rates have risen sharply among generation X and millennials based on a new study. Here is one woman's story.
By Vic Pasquantonio
By Liz Szabo, Kaiser Health News
The study raises the uncomfortable possibility that some women who believe their lives were saved by mammograms were actually harmed by cancer screenings that led to surgery, radiation and even chemotherapy that they didn’t need.
By Michelle Andrews, Kaiser Health News
33 percent of patients with HIV and lung cancer failed to receive any treatment for the cancer compared with 14 percent of those who weren’t infected.
By PBS NewsHour
The American Cancer Society has revised its mammogram guidelines, recommending that women with an average risk of cancer start screenings at age 45, not 40. Judy Woodruff examines the guidelines and the debate with Dr. Richard Wender of the American…
Promising Breast Cancer Treatment Averts 'Collateral Damage' to Healthy Cells…
Last week, a government panel issued a hotly-debated recommendation that most women wait until age 50 to begin getting regular mammograms to screen for breast cancer. Two experts answered your questions on the new guidelines.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.